Author Title Type [ Year(Asc)]
Filters: Author is Yousefi, Mehdi  [Clear All Filters]
Abolhasan, R., Mehdizadeh, A., Rashidi, M.Reza, Aghebati-Maleki, L., and Yousefi, M. (2019). Application of hairpin DNA-based biosensors with various signal amplification strategies in clinical diagnosis.Biosens Bioelectron129, 164-174.
Hassannia, H., Chaleshtari, M.Ghasemi, Atyabi, F., Nosouhian, M., Masjedi, A., Hojjat-Farsangi, M., Namdar, A., Azizi, G., Mohammadi, H., Ghalamfarsa, G., et al. (2019). Blockage of immune checkpoint molecules increases T cell priming potential of dendritic cell vaccine.Immunology.
Abdolmohammadi-Vahid, S., Pashazadeh, F., Pourmoghaddam, Z., Aghebati-Maleki, L., Abdollahi-Fard, S., and Yousefi, M. (2019). The effectiveness of IVIG therapy in pregnancy and live birth rate of women with recurrent implantation failure (RIF): A systematic review and meta-analysis.J Reprod Immunol134-135, 28-33.
Abbaszadeh, H., Ghorbani, F., Derakhshani, M., Movassaghpour, A., and Yousefi, M. (2019). Human umbilical cord mesenchymal stem cell-derived extracellular vesicles: A novel therapeutic paradigm.J Cell Physiol.
Yaghoubi, Y., Movassaghpour, A., Zamani, M., Talebi, M., Mehdizadeh, A., and Yousefi, M. (2019). Human umbilical cord mesenchymal stem cells derived-exosomes in diseases treatment.Life Sci116733.
Motavalli, R., Etemadi, J., Kahroba, H., Mehdizadeh, A., and Yousefi, M. (2019). Immune system-mediated cellular and molecular mechanisms in idiopathic membranous nephropathy pathogenesis and possible therapeutic targets.Life Sci116923.
Azizi, R., Soltani-Zangbar, M.Sadegh, Sheikhansari, G., Pourmoghadam, Z., Mehdizadeh, A., Mahdipour, M., Sandoghchian, S., Danaii, S., Koushaein, L., Kafil, H.Samadi, et al. (2019). Metabolic syndrome mediates inflammatory and oxidative stress responses in patients with recurrent pregnancy loss.J Reprod Immunol133, 18-26.
Rostamzadeh, D., Yousefi, M., Haghshenas, M.Reza, Ahmadi, M., Dolati, S., and Babaloo, Z. (2019). mTOR Signaling pathway as a master regulator of memory CD8 T-cells, Th17, and NK cells development and their functional properties.J Cell Physiol.
Hajialilo, M., Dolati, S., Abdolmohammadi-Vahid, S., Ahmadi, M., Kamrani, A., Eghbal-Fard, S., Ghassembaglou, A., Valizadeh, A., Shenas, M.Hossein Mu, Aghebati-Maleki, L., et al. (2019). Nanocurcumin: A novel strategy in treating ankylosing spondylitis by modulating Th17 cells frequency and function.J Cell Biochem.
Sheikhansari, G., Soltani-Zangbar, M.Sadegh, Pourmoghadam, Z., Kamrani, A., Azizi, R., Aghebati-Maleki, L., Danaii, S., Koushaeian, L., Hojat-Farsangi, M., and Yousefi, M. (2019). Oxidative stress, inflammatory settings, and microRNA regulation in the recurrent implantation failure patients with metabolic syndrome.Am J Reprod Immunole13170.
Nezhadi, J., Narenji, H., Barhaghi, M.Hossein So, Rezaee, M.Ahangarzad, Ghotaslou, R., Pirzadeh, T., Tanomand, A., Ganbarov, K., Bastami, M., Madhi, M., et al. (2019). Peptide nucleic acid-mediated re-sensitization of colistin resistance Escherichia coli KP81 harboring mcr-1 plasmid.Microb Pathog103646.
Pourakbari, R., Khodadadi, M., Aghebati-Maleki, A., Aghebati-Maleki, L., and Yousefi, M. (2019). The potential of exosomes in the therapy of the cartilage and bone complications; emphasis on osteoarthritis.Life Sci116861.
Chakari-Khiavi, F., Dolati, S., Chakari-Khiavi, A., Abbaszadeh, H., Aghebati-Maleki, L., Pourlak, T., Mehdizadeh, A., and Yousefi, M. (2019). Prospects for the application of mesenchymal stem cells in Alzheimer's disease treatment.Life Sci116564.
Kamrani, A., Alipourfard, I., Ahmadi-Khiavi, H., Yousefi, M., Rostamzadeh, D., Izadi, M., and Ahmadi, M. (2019). The role of epigenetic changes in preeclampsia.Biofactors.
Koushaeian, L., Ghorbani, F., Ahmadi, M., Eghbal-Fard, S., Zamani, M., Danaii, S., Yousefi, B., Jadidi-Niaragh, F., Hamdi, K., and Yousefi, M. (2019). The role of IL-10-producing B cells in Repeated Implantation Failure patients with cellular immune abnormalities.Immunol Lett.
Ahmadi, M., Abdolmohamadi-Vahid, S., Ghaebi, M., Dolati, S., Abbaspour-Aghdam, S., Danaii, S., Berjis, K., Madadi-Javid, R., Nouri, Z., Siahmansouri, H., et al. (2019). Sirolimus as a new drug to treat RIF patients with elevated Th17/Treg ratio: A double-blind, phase II randomized clinical trial.Int Immunopharmacol74, 105730.
Derakhshani, M., Abbaszadeh, H., Movassaghpour, A.Akbar, Mehdizadeh, A., Ebrahimi-Warkiani, M., and Yousefi, M. (2019). Strategies for elevating hematopoietic stem cells expansion and engraftment capacity.Life Sci116598.
Ahmadi, M., Yousefi, M., Abbaspour-Aghdam, S., Dolati, S., Aghebati-Maleki, L., Eghbal-Fard, S., Khabbazi, A., Rostamzadeh, D., Alipour, S., Shabani, M., et al. (2018). Disturbed Th17/Treg balance, cytokines, and miRNAs in peripheral blood of patients with Behcet's disease.J Cell Physiol.
Asghari, S., Valizadeh, A., Aghebati-Maleki, L., Nouri, M., and Yousefi, M. (2018). Endometriosis: Perspective, lights, and shadows of etiology.Biomed Pharmacother106, 163-174.
Eghbal-Fard, S., Yousefi, M., Heydarlou, H., Ahmadi, M., Taghavi, S., Movasaghpour, A., Jadidi-Niaragh, F., Yousefi, B., Dolati, S., Hojjat-Farsangi, M., et al. (2018). The imbalance of Th17/Treg axis involved in the pathogenesis of preeclampsia.J Cell Physiol.
Jafarzadeh, S., Ahmadi, M., Dolati, S., Aghebati-Maleki, L., Eghbal-Fard, S., Kamrani, A., Behrad, B., Roshangar, L., Jadidi-Niaragh, F., Yousefi, B., et al. (2018). Intravenous immunoglobulin G treatment increases live birth rate in women with recurrent miscarriage and modulates regulatory and exhausted regulatory T cells frequency and function.J Cell Biochem.
Dianat-Moghadam, H., Rokni, M., Marofi, F., Panahi, Y., and Yousefi, M. (2018). Natural killer cell-based immunotherapy: From transplantation toward targeting cancer stem cells.J Cell Physiol.
Ahmadi, M., Ghaebi, M., Abdolmohammadi-Vahid, S., Abbaspour-Aghdam, S., Hamdi, K., Abdollahi-Fard, S., Danaii, S., Mosapour, P., Koushaeian, L., Dolati, S., et al. (2018). NK cell frequency and cytotoxicity in correlation to pregnancy outcome and response to IVIG therapy among women with recurrent pregnancy loss.J Cell Physiol.
Mihanfar, A., Attari, J.Aghazadeh, Mohebbi, I., Majidinia, M., Kaviani, M., Yousefi, M., and Yousefi, B. (2018). Ovarian cancer stem cell: A potential therapeutic target for overcoming multidrug resistance.J Cell Physiol.
Rikhtegar, R., Pezeshkian, M., Dolati, S., Safaie, N., Rad, A.Afrasiabi, Mahdipour, M., Nouri, M., Jodati, A.Reza, and Yousefi, M. (2018). Stem cells as therapy for heart disease: iPSCs, ESCs, CSCs, and skeletal myoblasts.Biomed Pharmacother109, 304-313.